ask="266.00"
ask_size="200"
average_daily_volume="376569"
bid="20.69"
bid_size="2000"
book_value="3.21"
change="-0.36"
change_from_200_day_moving_average="8.84"
change_from_50_day_moving_average="3.76"
change_from_52_week_high="-1.11"
change_From_52_week_low="17.47"
change_in_percent="-1.57%"
close="22.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7129000"
high="23.57"
high_52_weeks="23.75"
last_trade_date="2/16/2017"
last_trade_price="22.64"
last_trade_size="3772"
last_trade_time="4:00pm"
low="21.17"
low_52_weeks="5.17"
market_capitalization="225.34M"
moving_average_200_day="13.80"
moving_average_50_day="18.88"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="23.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+64.11%"
percent_change_from_50_day_moving_average="+19.95%"
percent_change_from_52_week_high="-4.67%"
percent_change_from_52_week_low="+337.91%"
previous_close="23.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.17"
price_per_sales="4049.94"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="748364"
weeks_range_52="5.17 - 23.75"
